CD244 and head and neck squamous cell carcinoma: CD244 expression was increased in head and neck squamous cell carcinoma (HNSCC) and negatively correlated with CD8+ T-cell infiltrate, suggesting that CD244 could be an immunotherapy target in HNSCC (51).